Mandeep Singh
About Mandeep Singh
Data last updated:
Mandeep Singh is a Managing Director at Unimarck Pharma (India) Limited (since 2015) and Director at Teriot Pharmaceuticals Private Limited (since 2000). The companies operate in Pharma. The largest current company by reported revenue is Unimarck Pharma (India) Limited at ₹58.24 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unimarck Pharma (India) Limited U24232CH1984PLC005768 | Managing Director | 03 Dec 2015 | 1984 | ₹58.24 Cr (FY 2025) | Active |
 Teriot Pharmaceuticals Private Limited U51397PB2000PTC023355 | Director | 08 Feb 2000 | 2000 | Active |
Board colleagues of Mandeep Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gagandeep Bhatia | 00660772 | Unimarck Pharma (India) Limited | Whole-Time Director |
| Harleen Kaur Bhatia | 07414410 | Unimarck Pharma (India) Limited , Teriot Pharmaceuticals Private Limited | Director |
| Harsh Bhatia | 00659651 | Unimarck Pharma (India) Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mandeep Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mandeep Singh
Mandeep Singh currently holds 2 directorships: Unimarck Pharma (India) Limited (Managing Director, since 03 Dec 2015, revenue ₹58.24 Cr (FY 2025)); Teriot Pharmaceuticals Private Limited (Director, since 08 Feb 2000).
Mandeep Singh was first appointed on 08 Feb 2000 as Director at Teriot Pharmaceuticals Private Limited. The most recent appointment on record is 03 Dec 2015 at Unimarck Pharma (India) Limited.
The current boards of Mandeep Singh's companies include Gagandeep Bhatia (Unimarck Pharma (India) Limited), Harleen Kaur Bhatia (Unimarck Pharma (India) Limited), Harsh Bhatia (Unimarck Pharma (India) Limited).